Fluticasone Propionate Nasal Spray USP — Class II drug recall D-0349-2024
Ongoing recall by Golden State Medical Supply Inc., reported 2024-03-06, distributed nationwide. CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex
| Recall number | D-0349-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Golden State Medical Supply Inc., Camarillo, CA, United States |
| Recall initiated | 2024-02-14 |
| Classified | 2024-02-23 |
| Reported by FDA | 2024-03-06 |
| Distributed | Nationwide (US) |
| Quantity | 59,712 bottles |
| Reason classes | cgmp |
| Pathogens | burkholderia |
| NDC | 60429-0195, 60429-0195-15 |
| Lot numbers | TX5275 |
| Expiration dates | 2026-10-31 |
Product
Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only, Manufactured by: Apotek Inc., Toronto, Ontario, Cananda, Marketed by: GSMS Incorporated, Camarillo, CA, NDC 60429-195-15
Reason for recall
CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0349-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.